Helmut Laumen

Helmut Laumen

Auto-generated profile, based on publicly available information

Helmut Laumen

Department of Internal Medicine I, University Medicine Halle (UMH), Martin Luther University Halle-Wittenberg (MLU), Halle (Saale), Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2000 in Blood
Verified
Journal Article
Open access
Teresa MarafiotiTeresa Marafioti
Teresa Marafioti
MHMichael Hummel
Michael Hummel
HFHans-Dieter Foss
Hans-Dieter Foss
HLHelmut Laumen
Helmut Laumen
PKPetra Korbjuhn
Petra Korbjuhn
HSHarald Stein
Harald Stein
Single cell studies aimed at clarifying the nature and clonality of Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin's disease (HD) have so far produced conflicting results. Using an improved single cell procedure, the HRS cells of 25 patients with nodular sclerosing HD lacking B- and T-cell antigens, with and without Epstein-Barr virus infection, were analyzed for the presence of immunoglobulin (Ig) gene rearrangements. One patient with HD developed follicular lymphoma 2 years later. Both lymphomas originated from a common precursor identified as a germinal center B cell. The data show that all but one of the investigated cases harbored rearranged Ig genes, which were clonal in all instances and carried a high load of somatic mutations. The Ig coding capacity was preserved in 18 of the 24 cases (75%) with rearrangements. However, expression of Ig messenger RNA was not detectable in the HRS cells with the exception of Ig kappa light chain expression in some tumor cells of 1 case. The lack of Ig gene transcription in HRS cells was confirmed by analyzing the HD cell lines L428 and KM-H2 in transient transfection experiments. An Ig promoter/enhancer reporter construct showed virtually no activity in these cells compared to 5 control B-cell lines. We conclude that (1) classical HD is a B-cell lymphoma in most instances, (2) HRS cells are clonal without any exception, (3) they are derived from germinal center B-cells that (4) mostly lack crippling mutations but (5) have consistently lost their Ig gene transcription ability, due to functional defects in the Ig gene regulatory elements.

15 January 2001 in Blood
Verified
Journal Article
Closed access
PDF file
HSHarald Stein
Harald Stein
Teresa MarafiotiTeresa Marafioti
Teresa Marafioti
HFHans-Dieter Foss
Hans-Dieter Foss
HLHelmut Laumen
Helmut Laumen
MHMichael Hummel
Michael Hummel
‪‪‪Brunangelo ‪Falini
‪Brunangelo ‪Falini
In contrast to the tumor cells (L&H cells) of lymphocyte predominant Hodgkin disease (LPHD), Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin disease (cHD) are unable to transcribe immunoglobulin, despite the presence of rearranged immunoglobulin genes. Although initial studies have suggested crippling immunoglobulin gene mutations to be the cause of absent immunoglobulin expression in cHD, recent work of our group has demonstrated an impaired activation of the immunoglobulin promoter as a superior mechanism. As immunoglobulin transcription is mainly regulated by the B-cell transcription factors Oct2 and BOB.1/OBF.1, we analyzed 35 cases of LPHD, 32 cases of cHD, and 2 Hodgkin disease cell lines for the expression of these transcription factors and also in parallel for immunoglobulin expression. Our results demonstrate an absence of Oct2 and/or BOB.1/OBF.1 in cHD and a striking overexpression of Oct2 in LPHD. Immunoglobulin expression was lacking in cHD but present in LPHD. Furthermore, the reintroduction of BOB.1/OBF.1 and Oct2 into cultured HRS cells restored the activity of cotransduced immunoglobulin promoter constructs. Our findings dismiss the concept that the different immunoglobulin expression in cHD and LPHD is due to disrupting mutations of immunoglobulin V genes in cHD but is most likely due to a down-regulation of Oct2 and/or BOB.1/OBF.1. This study further revealed Oct2 as a new and valuable marker for the identification of L&H cells and their distinction from HRS cells. The impairment of immunoglobulin transcription with a down-regulated synthesis of Oct2 and BOB.1/OBF.1 is the first established general recurrent defect found in HRS cells.

1 January 2014 in Cell
Verified
Journal Article
Closed access
MCMelina Claussnitzer
Melina Claussnitzer
SDSimon N. Dankel
Simon N. Dankel
BKBernward Klocke
Bernward Klocke
HGHarald Grallert
Harald Grallert
VGViktoria Glunk
Viktoria Glunk
MMMark I. McCarthy
Mark I. McCarthy

1 May 2020 in Gastroenterology
Verified
Journal Article
Closed access
Atsushi MasamuneAtsushi Masamune
Atsushi Masamune
HKHiroshi Kotani
Hiroshi Kotani
FSFranziska Lena Sörgel
Franziska Lena Sörgel
Jian-Min ChenJian-Min Chen
Jian-Min Chen
SHShin Hamada
Shin Hamada
TSTooru Shimosegawa
Tooru Shimosegawa

18 March 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
DSDerek Spieler
Derek Spieler
MKMaria Kaffe
Maria Kaffe
FKFranziska Knauf
Franziska Knauf
JBJose Bessa
Jose Bessa
JTJuan Tena
Juan Tena
JWJuliane Winkelmann
Juliane Winkelmann
Genome-wide association studies (GWAS) identified the MEIS1 locus for Restless Legs Syndrome (RLS), but causal single nucleotide polymorphisms (SNPs) and their functional relevance remain unknown. This locus contains a large number of highly conserved noncoding regions (HCNRs) potentially functioning as cis-regulatory modules. We analyzed these HCNRs for allele-dependent enhancer activity in zebrafish and mice and found that the risk allele of the lead SNP rs12469063 reduces enhancer activity in the Meis1 expression domain of the murine embryonic ganglionic eminences (GE). CREB1 binds this enhancer and rs12469063 affects its binding in vitro. In addition, MEIS1 target genes suggest a role in the specification of neuronal progenitors in the GE, and heterozygous Meis1-deficient mice exhibit hyperactivity, resembling the RLS phenotype. Thus, in vivo and in vitro analysis of a common SNP with small effect size showed allele-dependent function in the prospective basal ganglia representing the first neurodevelopmental region implicated in RLS.

1 July 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PKP. Krinninger
P. Krinninger
RER. Ensenauer
R. Ensenauer
KEK. Ehlers
K. Ehlers
KRK. Rauh
K. Rauh
JSJ. Stoll
J. Stoll
HLH. Laumen
H. Laumen
The activation of peripheral immune cells and the infiltration of immune cells into adipose tissue in obesity are implicated in the development of type 2 diabetes mellitus. The aim of the study was to compare peripheral immune cells from obese and normal-weight women with regard to composition of immune cell subpopulations, surface expression of the chemokine receptors (CCRs) CCR2, CCR3, CCR5, and CXCR3 (chemokine (C-X-C motif) receptor 3) and cell-intrinsic migration capacity. This was a case-control study. The study was conducted at a university clinical study center. Obese females and normal-weight females were included for fluorescence-activated cell sorting analysis and migration assays. Peripheral blood mononuclear cells were prepared from fasting blood samples and used for fluorescence-activated cell sorting analysis and migration assays. An increase in the percentages of CD14(+)CD16(+) monocytes was observed in obese subjects compared with controls. The CCR profile of monocytes differed significantly in the obese state; in particular, CCR2 levels were increased. In addition, a higher chemotactic activity of monocytes from obese subjects was observed in a migration assay, which was associated with both insulin resistance and CCR2 expression. Our results suggest that the enhanced intrinsic migratory capacity of peripheral monocytes in obese women may be due to the increased CCR expression, further supporting a link between peripheral immune cell dysfunction and obesity.